BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37169253)

  • 1. Serum Levels of Matrix Metalloproteinases in Patients Undergoing Endovascular Intervention for Peripheral Arterial Disease.
    Giagtzidis I; Karkos C; Kadoglou NPE; Spathis A; Papazoglou K
    Ann Vasc Surg; 2023 Aug; 94():154-164. PubMed ID: 37169253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Profile of Circulating Matrix Metalloproteinases in Patients Undergoing Lower Limb Endovascular Interventions for Peripheral Arterial Disease.
    Giagtzidis IT; Kadoglou NP; Mantas G; Spathis A; Papazoglou KO; Karakitsos P; Liapis CD; Karkos CD
    Ann Vasc Surg; 2017 Aug; 43():188-196. PubMed ID: 28288884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.
    Kobusiak-Prokopowicz M; Kaaz K; Marciniak D; Karolko B; Mysiak A
    Kidney Blood Press Res; 2021; 46(6):749-757. PubMed ID: 34801997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results.
    Georgiadis GS; Antoniou GA; Argyriou C; Schoretsanitis N; Nikolopoulos E; Kapoulas K; Lazarides MK; Tentes I
    J Endovasc Ther; 2019 Dec; 26(6):826-835. PubMed ID: 31464166
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
    Tayebjee MH; Lip GY; Blann AD; Macfadyen RJ
    Thromb Res; 2005; 115(3):205-10. PubMed ID: 15617743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the kallikrein-kinin system, metalloproteinases, and their tissue inhibitors in the in-stent restenosis after peripheral percutaneous angioplasty.
    Ribeiro MS; Dellalibera-Joviliano R; Becari C; Teixeira FR; Araujo PV; Piccinato CE; Campos CP; Evora PR; Joviliano EE
    Ann Vasc Surg; 2014 May; 28(4):1005-15. PubMed ID: 24440188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
    Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum levels of circulating matrix metalloproteinase MMP-9, MMP-2/TIMP-2 complex and TIMP-1 do not change significantly during normal pregnancy: a pilot study.
    Nissi R; Santala M; Talvensaari-Mattila A
    BMC Res Notes; 2021 Jan; 14(1):31. PubMed ID: 33482846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Levels of MMPs and TIMP-1 in Patients with Osteoarthritis After Recovery from COVID-19.
    Tuharov Y; Krenytska D; Halenova T; Kot L; Raksha N; Savchuk O; Prysiazhniuk L; Matkivska R; Falalyeyeva T; Ostapchenko L
    Rev Recent Clin Trials; 2023; 18(2):123-128. PubMed ID: 37231778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
    Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M
    PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
    Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
    J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.